Company · CIK 0000875045 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
BIOGEN INC. · BIIB
Insider activity reported against this company. All insider holders · Files at: BIVV. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 SForm 4 → | Aug 5, 4:03 pm EDT | Lloyd MinorDirector | 1,186 | $202.15 | $239,750 | 2,689 | −30.6% | 10b5-1 |
| Jun 9, 2026 AForm 4 → | Jun 11, 5:50 pm EDT | William A HawkinsDirector | 1,505 | — | — | 10,365 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 5:47 pm EDT | Stephen A SherwinDirector | 1,505 | — | — | 15,193 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 5:46 pm EDT | Eric K RowinskyDirector | 1,505 | — | — | 25,844 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 5:44 pm EDT | Jesus B MantasDirector | 1,505 | — | — | 11,263 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 5:34 pm EDT | Susan LangerDirector | 1,505 | — | — | 6,634 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 5:32 pm EDT | Monish D PatolawalaDirector | 1,505 | — | — | 5,215 | — | |
| Jun 9, 2026 AMForm 4 → | Jun 11, 5:21 pm EDT | Menelas N PangalosDirector | 3,875 | — | — | 3,875 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 5:17 pm EDT | Lloyd MinorDirector | 1,505 | — | — | 3,875 | — | |
| Jun 9, 2026 AForm 4 → | Jun 11, 5:09 pm EDT | Maria C FreireDirector | 2,005 | — | — | 8,820 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 AForm 4 → | Sep 3, 4:14 pm EDT | Michael PariniChief Legal Officer | 7,405 | — | — | 7,405 | — | |
| Jun 9, 2026 MForm 4 → | Jun 11, 5:21 pm EDT | Menelas N PangalosDirector | 2,370 | — | — | 0 | — |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.